Publications by authors named "Shuqiong You"
Article Synopsis
- This study investigated the connection between cytokine levels, disease severity (measured by PDAI), and specific antibodies in patients with pemphigus vulgaris (PV) compared to healthy individuals.
- It involved 62 PV patients and examined various cytokines and chemokines, which revealed increased levels of certain Th1, Th2, and Th17/Th22 cytokines in the PV group, but lower levels of specific chemokines.
- The research also found significant correlations between certain cytokines and disease severity, as well as associations between specific cytokines and antibody levels, suggesting a complex immune response in PV patients.
Objective: To retrospectively analyze the efficacy and safety of dupilumab in the treatment of bullous pemphigoid.
Methods: From October 2020 to October 2022, the medical records of patients with bullous pemphigoid who were treated with dupilumab in our department were collected retrospectively to analyze the therapeutic effect and changes in laboratory indexes.
Results: The records of a total of 11 patients with bullous pemphigoid who were treated with dupilumab was reviewed.